These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Risperidone-associated increase in triglyceride levels. Weinbrenner A; Peus V; Inta D; Englisch S; Zink M Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019 [No Abstract] [Full Text] [Related]
44. Risperidone-induced mania. Zolezzi M; Badr MG Ann Pharmacother; 1999 Mar; 33(3):380-1. PubMed ID: 10200867 [No Abstract] [Full Text] [Related]
45. Self-limited erythema multiforme with risperidone. Burke GV; Wong DA; Saunders CS; Pierre JM Gen Hosp Psychiatry; 2009; 31(3):295-6. PubMed ID: 19410111 [No Abstract] [Full Text] [Related]
46. Obsessional symptoms associated with risperidone treatment. Mahendran R Aust N Z J Psychiatry; 1998 Apr; 32(2):299-301. PubMed ID: 9588312 [TBL] [Abstract][Full Text] [Related]
47. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820 [TBL] [Abstract][Full Text] [Related]
48. Risperidone: a review of efficacy studies in adolescents with schizophrenia. Madaan V Drugs Today (Barc); 2009 Jan; 45(1):55-62. PubMed ID: 19271032 [TBL] [Abstract][Full Text] [Related]
49. Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia. Pandina GJ; Canuso CM; Youssef E; Kujawa M; Mahmoud R Hum Psychopharmacol; 2007 Jul; 22(5):326-7; author reply 328. PubMed ID: 17599334 [No Abstract] [Full Text] [Related]
50. Letters to the Editor. Clin Schizophr Relat Psychoses; 2016; 10(1):22-5. PubMed ID: 27074332 [No Abstract] [Full Text] [Related]
51. Atypical antipsychotic medication: a nightmarish problem! Bretag-Norris R; Alexander J Aust N Z J Psychiatry; 2012 Sep; 46(9):909. PubMed ID: 22956572 [No Abstract] [Full Text] [Related]
52. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone. Kopala LC; Fredrikson D; Good KP; Honer WG Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777 [No Abstract] [Full Text] [Related]
53. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK; N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203 [TBL] [Abstract][Full Text] [Related]
54. Leukopenia during therapy with risperidone long-acting injectable: two case reports. Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449 [No Abstract] [Full Text] [Related]